T O EXERT ITS biological activity, T 4 , which is a major secretory product of thyroid gland, needs to be converted to T 3 by iodothyronine deiodinase (1). Iodothyronine deiodinase, which converts T 4 to T 3 , has two main subgroups (2). Type 1 iodothyronine deiodinase (D1) is present in thyroid gland, liver, kidney, and many other tissues, whereas D2 is present in a limited number of tissues, including central nervous system, anterior pituitary, and brown fat in the rat. Michaelis-Menten constant (K m ) of D2 is approximately 1-10 nm for T 4 , which is 100 times lower than that of D1. D2 is relatively insensitive to inhibition by 6-propyl-2-thiouracil (PTU), which inhibits D1. D1 activity is known to decrease in the hypothyroid state, and D1 is believed to have a primary role in maintaining circulating T 3 levels. D2 activity, in contrast, increases in the hypothyroid state, and D2 is considered to play a critical role in providing local T 3 to regulate intracellular T 3 concentration (1).
T O EXERT ITS biological activity, T 4 , which is a major secretory product of thyroid gland, needs to be converted to T 3 by iodothyronine deiodinase (1) . Iodothyronine deiodinase, which converts T 4 to T 3 , has two main subgroups (2) . Type 1 iodothyronine deiodinase (D1) is present in thyroid gland, liver, kidney, and many other tissues, whereas D2 is present in a limited number of tissues, including central nervous system, anterior pituitary, and brown fat in the rat. Michaelis-Menten constant (K m ) of D2 is approximately 1-10 nm for T 4 , which is 100 times lower than that of D1. D2 is relatively insensitive to inhibition by 6-propyl-2-thiouracil (PTU), which inhibits D1. D1 activity is known to decrease in the hypothyroid state, and D1 is believed to have a primary role in maintaining circulating T 3 levels. D2 activity, in contrast, increases in the hypothyroid state, and D2 is considered to play a critical role in providing local T 3 to regulate intracellular T 3 concentration (1) .
Though the source of T 3 mainly depends on circulating T 3 in most tissues, local intracellular conversion of T 4 to T 3 is an important source of T 3 in certain tissues where D2 exists. The local conversion of T 4 to T 3 by D2 is considered of physiological importance in regulating anterior pituitary function, especially the inhibition of TSH secretion by thyroid hormones (1, 3) .
ACTH is secreted from pituitary corticotrophs to regulate adrenocortical functions. ACTH secretion is stimulated by CRH secreted from hypothalamus and negatively regulated by glucocorticoid secreted from adrenal glands (4, 5) . The physiological role of thyroid hormones in the regulation of functions of pituitary corticotrophs, including the secretion of ACTH, is not fully understood. Recently, it has been reported that thyroid hormones regulate prohormone convertase (PC)1 and PC2, members of the mammalian family of the substilisin-like endoproteases, which are responsible for processing prohormone, proopiomelanocortin, to generate ACTH (6 -8) . Therefore, it is of considerable importance to study the presence and the regulation of thyroid hormone activation mechanism in pituitary corticotrophs.
In the present study, we have characterized iodothyronine deiodinating activity and identified D2 expression in ACTHsecreting AtT-20 mouse pituitary tumor cells, which is a well accepted model of pituitary corticotrophs (6, 9) . 
Materials and Methods Materials

Cell culture
AtT-20/D16v-F2 cells and GH3 cells were obtained from American Type Culture Collection (Manassas, VA). AtT-20/D16v-F2 cells were cultured in DMEM containing 10% FBS, and GH3 cells were cultured in Ham's F10 medium containing 15% horse serum and 2.5% FBS at 37 C in the humidified atmosphere of 5% CO2-95% air, and the culture medium was changed every 3 d. Cells were grown to semiconfluence in the culture medium in 6-well or 12-well culture plates (Becton Dickinson and Co., Franklin Lakes, NJ), and then incubated in the same medium containing the compounds to be tested for the periods indicated. The Abbreviations: D1 and D2, Type 1 and type 2 iodothyronine deiodinase; DEX, dexamethasone; DTT, dithiothreitol; PC, prohormone convertase; PTU, 6-propyl-2-thiouracil; SSC, saline sodium citrate. culture medium with thyroid hormone-stripped FBS (10) was used for 24 h before harvest, when the effects of thyroid hormones were tested.
Measurement of iodothyronine deiodinase activity
Iodothyronine deiodinase activity was measured as previously described (11) , with minor modifications (12) . Briefly, AtT-20 cells or GH3 cells per each well were washed twice with PBS, scraped off, and transferred into 1.5 ml ice-cold assay buffer [100 mm potassium phosphate (pH 7.0), containing 1 mm EDTA and 20 mm dithiothreitol (DTT)]. After centrifugation at 3,000 rpm for 10 min at 4 C, the resultant precipitates were sonicated in 100 l of the assay buffer per tube and were incubated in a total vol of 50 l with 2 nm or indicated amount of [ 125 I]T 4 or [ 125 I]rT 3 , which was purified using LH-20 column chromatography on the day of the experiment, in the presence or absence of 1 mm PTU or in the presence of 1 mm iopanoic acid, for indicated periods at indicated temperatures, in duplicate. After the characterization of the deiodinating activity in AtT-20 cells, the sonicates were routinely incubated with 2 nm [ 125 I]T 4 in the presence of 1 mm PTU at 37 C for 1 h. The reaction was terminated by adding 100 l ice-cold 2% BSA and 800 l ice-cold 10% trichloroacetic acid. After centrifugation at 3,000 rpm for 10 min at 4 C, the supernatant was applied onto a small column packed with AG 50W-X2 resin (bed vol ϭ 1 ml) and then eluted with 2 ml of 10% glacial acetic acid (column method). Separated 125 I was counted with a ␥-counter. Nonenzymatic deiodination was corrected by subtracting I Ϫ released in control tubes without cell sonicates. The protein concentration was determined by Bradford's method using BSA as a standard (13) . The deiodinating activity was calculated as femtomoles of I Ϫ released/mg protein⅐h, after multiplication by a factor of 2 to correct random labeling at the equivalent 3Ј and 5Ј positions. In some experiments, the incubation mixtures were extracted with 2 vol of absolute ethanol after the addition of 5 l of 10 m T 4 and T 3 , and analyzed by descending paper chromatography (hexane:tertiary amyl alcohol:2 n ammonia, 1:5:6) (14, 15).
Preparation of cRNA probes
Because the expression of D2 mRNA has been demonstrated in mouse cerebral tissue, total RNA was extracted from mouse cerebral tissue obtained by a modified acid guanidinium thiocyanate-phenol-chloroform method according to Chomczynski and Sacchi (16) . Total RNA was reverse transcribed, and a mouse D2 cDNA fragment containing residues 180 -614 (numbering of residues as GenBank accession no. AF096875) (17) was amplified by PCR (Perkin-Elmer Applied Biosystems, Foster City, CA). The PCR product was fractionated on a 1% agarose gel and subsequently cloned into pCRII TA-cloning vector (Invitrogen, San Diego, CA). Sequencing analysis (Perkin-Elmer Applied Biosystems) confirmed the identity of the amplified DNA. The cRNA probe for mouse D2 was synthesized with [␣-32 P]uridine 5Ј-triphosphate and T7 RNA polymerase. Rat D2 cRNA probe was prepared as previously described (18) .
RNA preparation and Northern analysis
Total RNA was isolated from each well, and Northern analysis was performed as previously described (18) . Twenty micrograms of total RNA per each lane was electrophoresed on a 1.4% agarose gel containing 0.66 m formaldehyde and transferred overnight in 20ϫ saline sodium citrate (SSC) (1ϫ SSC: 150 mm sodium chloride and 15 mm trisodium citrate) to a nylon membrane (Biodyne; Pall BioSupport Corp., East Hills, NY). RNA was cross-linked to the nylon membrane with a UV Stratalinker (Stratagene, San Diego, CA). The membrane was prehybridized with the hybridization buffer (50% formamide, 0.2% SDS, 5% dextran sulfate, 50 mm HEPES, 5ϫ SSC, 5ϫ Denhardt's solution, and 100 g/ml denatured salmon sperm DNA) at 68 C for 2 h. Subsequently, the membrane was hybridized at 68 C overnight with the hybridization buffer containing a mouse or a rat D2 cRNA probe. The membrane was washed twice in 2ϫ SSC, 0.1% SDS at 25 C for 15 min and twice in 0.1ϫ SSC, 0.1% SDS at 68 C for 1 h. Autoradiography was established by exposing the filters for 4 -24 h to x-ray film (Kodak XAR-2; Eastman Kodak Co., Rochester, NY) at Ϫ70 C. After the detection of D2 mRNA, the probe was stripped off and blots rehybridized with ␤-actin cRNA probe as a control. Hybridization and washing were performed as described above, and the membrane was exposed for 1 h. mRNA levels were quantitated by densitometry using NIH Image, version 1.61, and the OD of the D2 band was corrected for ␤-actin. RNA samples for comparison were analyzed on the same blot (18) .
Statistics
Statistical differences were evaluated by Student's t test or ANOVA with the Newman-Keuls test for multiple comparisons.
Results
Analysis of iodothyronine deiodinase activity in AtT-20 cells
The deiodinating activity was measured by the release of I Ϫ from [
125 I]T 4 in the presence of 20 mm DTT using the column method. Significant deiodinating activity was detectable in the sonicate of AtT-20/D16v-F2 cells. The T 4 deiodination was dependent on the incubation period up to 2 h and the protein concentration of AtT-20 cells as shown in Fig.  1 . Incubation at 4 C or preheating the cell sonicate at 56 C for 30 min completely abolished the deiodination. The deiodinating activity was not influenced by 1 mm PTU but was completely inhibited by 1 mm iopanoic acid. From the double reciprocal plot, kinetic constants were calculated to be: K m ϭ3.07 nm, Vmax ϭ 88. 5 4 in the presence of 20 mm DTT and 1 mm PTU and subsequently the reaction products were analyzed by descending paper chromatography, there were only three definable peaks corresponding to I Ϫ , T 4 , and T 3 , and radioactivity in the I Ϫ peak was comparable with that in the T 3 peak. These results indicate that all the characteristics of the deiodinating activity in AtT-20/D16v-F2 cells are compatible with D2.
Effects of CRH, cAMP, and dexamethasone (DEX) on D2 expression in AtT-20 cells
Northern analysis of total RNA prepared from AtT-20/ D16v-F2 cells using mouse D2 cRNA probe clearly demonstrated the single hybridization signal of approximately 7 kb in size as shown in Fig. 2A , indicating the presence of D2 mRNA, as well as D2 activity, in AtT-20/D16v-F2 cells.
Although 10 Ϫ8 m CRH or 10 Ϫ3 m (Bu)2cAMP slightly stimulated D2 activity (1.4-fold and 2.3-fold, respectively) and D2 mRNA (1.4-fold and 1.7-fold, respectively) in AtT-20 cells, 10 Ϫ6 m DEX significantly stimulated D2 activity (3.6-fold) and D2 mRNA (3.9-fold). In the presence of 10 -6 M DEX, 10
Ϫ8
m CRH or 10 Ϫ3 m (Bu)2cAMP markedly stimulated D2 activity (5.8-fold and 12-fold, respectively) and D2 mRNA (6.3-fold and 10.6-fold, respectively) as shown in Fig. 2, A m DEX plus 10 Ϫ8 m CRH significantly stimulated D2 expression in AtT-20 cells as shown in Fig. 3 . In these experiments, medium change itself slightly increased D2 expression, as reported in cultured mouse neuroblastoma cells (19) .
Effects of graded doses of DEX or CRH were studied in the next experiment. CRH itself did not stimulate D2 expression up to 10 Ϫ8 m, but CRH stimulated D2 expression in a dosedependent manner in the presence of 10 Ϫ6 m DEX (data not shown). In addition, DEX stimulated D2 expression in a dose-dependent manner, and this increase was augmented by the addition of 10 Ϫ8 m CRH (data not shown). 
Effects of various steroids on D2 expression in AtT-20 cells
Effects of 10 Ϫ6 m of various steroids on D2 expression were studied. As shown in Fig. 4 , testosterone or ␤-estradiol did not increase D2 expression, although corticosterone stimulated D2 activity (2.4-fold) and D2 mRNA (3-fold) in AtT-20 cells. The potency of stimulation of D2 expression by corticosterone was less than that of DEX. These results indicate that glucocorticoid, but not sex steroids, stimulates D2 expression in AtT-20 cells.
Effects of thyroid hormones on D2 activity in AtT-20 cells
One of the important features of D2 is the negative regulation of the enzyme activity by thyroid hormones. Addition of thyroid hormones to the incubation medium for 6 h decreased the deiodinating activity in AtT-20 cells, and the potency of the inhibitory effect was T 4 ϾrT 3 ϾT 3 as shown in Fig. 5 . The inhibition of deiodinating activity in AtT-20 cells by thyroid hormones further supports the presence of authentic D2 activity in cultured AtT-20 cells. When the effects of thyroid hormones on D2 mRNA were studied, 10 Ϫ7 m of T 3 , T 4 , or rT 3 did not alter D2 mRNA levels up to 6 h (data not shown). These results suggest that the thyroid hormones inhibit D2 expression mainly at the posttranslational level in AtT-20 cells in these experimental conditions.
Effects of cAMP and DEX on D2 expression in GH3 cells
Because it was reported that D2 activity was present in GH3 rat pituitary tumor cells (20, 21) , effects of DEX and cAMP on D2 expression in GH3 cells were also studied. As shown in Fig. 6, 10 Ϫ6 m DEX or 10 Ϫ3 m (Bu)2cAMP slightly stimulated D2 activity (1.5-fold) and D2 mRNA (1.6-fold and 1.8-fold, respectively), and 10 Ϫ6 m DEX plus 10 Ϫ3 m (Bu)2cAMP stimulated D2 activity (2.8-fold) and D2 mRNA (2.6-fold) in GH3 cells. Ϫ6 M of various steroids for 6 h. The OD of the D2 band was corrected for ␤-actin, and D2 mRNA was expressed as a percentage of D2 mRNA in control (incubated with medium only). D2 activity shown represents the mean Ϯ SE of three wells. *, P Ͻ 0.01 (Newman-Keuls test).
Discussion
The present results have clearly demonstrated that iodothyronine deiodinating activity is present in the ACTHsecreting AtT-20/D16v-F2 mouse pituitary tumor cell line, which is a well-accepted model of anterior pituitary lobe corticotrophs (6, 9) . Iodothyronine deiodinating activity in AtT-20 cells was dependent on protein concentrations, incubation period, and temperature. These characteristics clearly indicate its enzymatic nature. Iodothyronine deiodinating activity was not inhibited by 1 mm PTU and showed low K m for T 4 or rT 3 . In addition, the deiodinating activity was decreased by the addition of thyroid hormones to the culture medium. Iodothyronine deiodinating activity in AtT-20 cells, therefore, has characteristics compatible with D2 (1, 2). Northern analysis using mouse D2 cRNA probe clearly demonstrated the hybridization signals of approximately 7 kb in size in AtT-20 cells. The size of D2 mRNA demonstrated in AtT-20 cells was in agreement with the previous observations (17) . The present results seem to be the first demonstration of the expression of D2, which plays a pivotal role in providing local intracellular T 3 , in AtT-20 mouse pituitary tumor cells that secrete ACTH.
The presence of iodothyronine deiodinase in pituitary corticotrophs has been controversial. In old literature, it was demonstrated that mouse adrenocorticotropic tumors did not show iodothyronine deiodination, although thyrotropic tumors showed deiodination (22) . However, recent studies showed that D2 activity and D2 mRNA were detected in human pituitary tumors, including Cushing's disease (23, 24) , suggesting the expression of D2 in human pituitary corticotrophs.
Because D2 activity in AtT-20 cells was inhibited by thyroid hormones, mainly at the posttranslational level, in the present study, D2 expression in pituitary corticotrophs could be increased in the hypothyroid state, as demonstrated in the rat central nervous system, pituitary, and brown adipose tissue in vivo (1) . It is, therefore, possible that D2 in pituitary corticotrophs may play a role in protecting corticotrophs from local T 3 deficiency in hypothyroidism.
In the present study, both D2 activities and D2 mRNA levels were rapidly stimulated by (Bu)2cAMP in AtT-20 cells. These results indicate that D2 expression in AtT-20 cells is regulated by a cAMP-dependent mechanism at the pretranslational level, as previously reported in human skeletal muscle cells, human thyroid follicular cells, rat astrocytes, and rat pineal glands (15, 18, 25, 26) . Recently, cAMP response element was reported to be present in the human D2 promoter region (26, 27, 28) , suggesting that the transcriptional regu- The present results demonstrated that glucocorticoid significantly stimulated D2 expression in AtT-20 cells. Furthermore, CRH markedly stimulated D2 expression in the presence of DEX, presumably via a cAMP-dependent mechanism. These results suggest the permissive role of glucocorticoid in the stimulation of D2 expression by CRH in AtT-20 cells. In the present study, cAMP stimulated D2 expression more potently than CRH in AtT-20 cells. CRH is also known to stimulate phospholipase C-diacylglycerol-inositolposphate-Ca 2ϩ signaling cascade (29) , which may modulate the stimulatory effect of cAMP on D2 expression. It is of interest that D2 expression is increased by factors that either stimulate or inhibit ACTH secretion, namely CRH and glucocorticoid, respectively. D2 activity was reported to be present in GH3 rat pituitary tumor cells (20, 21) , and DEX or cAMP was demonstrated to cause modest increases in D2 mRNA in GH4C1 rat pituitary tumor cells (30) . In the present study, DEX or cAMP slightly stimulated D2 expression, and DEX plus cAMP modestly stimulated D2 expression in GH3 cells. Thus, the magnitude of stimulation of D2 expression by DEX and cAMP in GH3 cells was less than that in AtT-20 cells. It was also reported that glucocorticoid showed a permissive role in the stimulation of D2 activity by TPA in rat astroglial cells (31) . In contrast, DEX was reported to decrease D2 activity in cultured mouse neuroblastoma cells (32) . Therefore, the effect of glucocorticoid on D2 expression could be different among tissues where D2 exists.
The physiological importance of intracellular thyroid hormone activation by D2 has been clearly demonstrated in certain tissues. Adenohypophyseal T 3 production by D2 plays an important role in feedback regulation of TSH secretion by thyroid hormones (1, 3) . In rat brown adipose tissue, the expression of uncoupling protein is regulated by locally generated T 3 , which is provided by D2 (33, 34) . Recently, it has been reported that thyroid hormone regulates PC1 and PC2, members of the mammalian family of the substilisin-like endoproteases, which are responsible for processing prohormone, proopiomelanocortin, to generate ACTH (6) . It has been shown that T 3 negatively regulates PC1 and PC2 expression at the transcriptional level and that functional negative thyroid hormone response elements exist in human PC1 and PC2 promoter (7, 8) . Furthermore, T 4 treatment in vivo has been shown to decrease PC2 mRNA (6) . Therefore, D2 in pituitary corticotrophs may play a role in the regulation of PCs by thyroid hormones. It is also of interest to study the possible role of locally produced T 3 by D2 in the regulation of other corticotroph-specific genes.
In summary, the present results demonstrate the expression of functional D2 in ACTH-secreting AtT-20 mouse pituitary tumor cells, and its activity is stimulated by glucocorticoid and CRH and inhibited by thyroid hormones, which may open novel perspectives on the roles of thyroid hormone metabolism in the physiological regulation of pituitary corticotrophs.
